Enzo Spisni is an Associate Professor at the University of Bologna. Since 2000, he has carried out research in the physiology of the gastro-intestinal tract and human nutrition. His research interests are focused in particular on intestinal inflammation and on the relationships between food, intestinal microbiota and low-grade chronic inflammation. Currently, he focuses his research on the modulation of intestinal microbiota through food and non-probiotic food supplements. Engaged in national and international research projects, he collaborates with various companies in the Food and Pharma sectors. Author of over 80 publications, he is CEO of Startup Targeting Gut Disease, a company with shareholding of the University of Bologna.
Maria Chiara Valerii graduated in 2006 with a degree in Biological Sciences, with a focus on pathophysiology. In 2010, she completed a PhD in Gastroenterological and Transplantation Medical-Surgical Sciences. In 2011, she obtained a second-level Master's degree in Pre-clinical and Clinical Drug Research and Development. Her scientific output includes 36 publications, corresponding to 880 citations (h-index 16) (Scopus, 8 November 2023).
